Evaxion A (EVAX) Invested Capital (2019 - 2025)
Evaxion A posted quarterly Invested Capital of $22.6 million for Q4 2025, up 246.52% year-on-year from $6.5 million in Q4 2024, and up 12169.57% on a QoQ basis from $184000.0 in Q2 2025.
Evaxion A (EVAX) has 7 years of Invested Capital data on file, last reported at $22.6 million in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 246.52% year-over-year to $22.6 million; the trailing twelve-month figure through Mar 2026 stood at $184000.0 (up 16.46% YoY), and the FY2025 full-year result was $22.6 million, up 246.52% from the prior year.
- Invested Capital for Q4 2025 stood at $22.6 million, up from $184000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $36.3 million in Q4 2021 and bottomed at $119000.0 in Q2 2022.
- The 5-year median for Invested Capital is $184000.0 (2025), against an average of $8.1 million.
- The widest annual swing landed in 2021, when Invested Capital soared 414.03%; it then plunged 79.05% in 2023.
- A 5-year view of Invested Capital shows it stood at $36.3 million in 2021, then slumped by 48.45% to $18.7 million in 2022, then slumped by 79.05% to $3.9 million in 2023, then surged by 66.24% to $6.5 million in 2024, then jumped by 246.52% to $22.6 million in 2025.
- The last three Invested Capital figures came in at $22.6 million (Q4 2025), $184000.0 (Q2 2025), and $6.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.58 Mn |
| Jun 30, 2025 | 184,000.00 |
| Dec 31, 2024 | 6.52 Mn |
| Jun 30, 2024 | 158,000.00 |
| Dec 31, 2023 | 3.92 Mn |
| Jun 30, 2023 | 152,000.00 |
| Dec 31, 2022 | 18.70 Mn |
| Jun 30, 2022 | 119,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 36.28 Mn |
| Sep 30, 2021 | 159,000.00 |
| Dec 31, 2020 | 7.06 Mn |
| Dec 31, 2019 | 9.40 Mn |